德勤：2021年中国生物科技园产业园报告-借力生态系统制胜（英文版）（16页）.pdf

《德勤：2021年中国生物科技园产业园报告-借力生态系统制胜（英文版）（16页）.pdf》由会员分享，可在线阅读，更多相关《德勤：2021年中国生物科技园产业园报告-借力生态系统制胜（英文版）（16页）.pdf（16页珍藏版）》请在三个皮匠报告上搜索。

1、Chinas Biotech Parks Leveraging the ecosystem for success2册子 / 报告标题 | 章节标题The status and development of BPIPs in China 2Overview of tax and financial supporting policies for 5the Chinese biopharmaceutical industry Policy considerations for biopharma companies in China 8Conclusion 10Contacts 111China

2、s Biotech Parks Leveraging an ecosystem for successIntroductionThe Chinese government has recognized the biopharmaceutical industry (BPI) as of strategic importance and been vigorously advocating its optimum development in China. Creating the necessary infrastructure for industry development has bee

3、n and remains to be one of its key objectives and ambitions. Many local governments have established special biopharmaceutical industrial parks (BPIPs) and issued policies to support and promote industry development. Market participants need to pay close attention to these developments to maximize t

4、heir chances of success in investment and management. BPI enterprises are high risk, require substantial investment and advanced technology, and have a lengthy development cycle. BPIPs have been one of the main contributors to the rapid development of the Chinese biopharmaceutical industry. Chinese

5、BPIPs have become much more developed, and are attracting a growing number of domestic and multinational biopharmaceutical enterprises. BPIPs are also the main platforms through which local governments seek to attract, foster and promote industry development. BPIPs across China are being transformed

6、 and upgraded to provide enterprises with more innovative resources and more efficient services. This paper presents the current development conditions of Chinese BPIPs, summarizes common local support policies, and discusses how biopharma enterprises can use industrial parks and related policies to